Attached files

file filename
8-K - ALLIANCE FORM 8-K - BioCube, INC.form8k.htm
EX-99.2 - EXHIBIT 99.2 - BioCube, INC.ex992.htm
EX-10.1 - EXHIBIT 10.1 - BioCube, INC.ex101.htm
EX-17.2 - EXHIBIT 17.2 - BioCube, INC.ex172.htm
EX-17.1 - EXHIBIT 17.1 - BioCube, INC.ex171.htm
 

 

 
EXHIBIT 99.1
 
UNAUDITED FINANCIAL STATEMENTS OF BIOCUBE, INC.
 
YEARS ENDED DECEMBER 31, 20089 AND 2008
 
 
 
 

 
 
 

 

 
BIOCUBE, INC.
(A Development Stage Company)
BALANCE SHEETS
DECEMBER 31, 2009 AND 2008
ASSETS
 
   
December 31
   
December 31
 
   
2009
   
2008
 
CURRENT ASSETS
           
Cash
  $ 1,904     $ 0  
                 
Total Current Assets
    1,904       0  
                 
PROPERTY AND EQUIPMENT
               
Decontamination system
    28,500       0  
                 
Total Property and Equipment
    28,500       0  
                 
TOTAL ASSETS
    30,404       0  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
                 
CURRENT LIABILITIES
               
Accounts Payable
    26,600       0  
Accrued salaries
    180,000       0  
Other accrued expenses
    269       0  
Short term loans
    14,175       0  
                 
Total Current Liabilities
    221,044       0  
                 
LONG-TERM LIABILITIES
               
Note payable related party
    10,000       0  
                 
Total Long-Term Liabilities
    10,000       0  
                 
Total Liabilities
    231,044       0  
                 
STOCKHOLDERS' EQUITY
               
Capital Stock
    4,500       4,000  
Additional paid-in capital
    29,500       0  
Retained Earnings
    (234,640 )     0  
                 
Total Stockholders' Equity
    (200,640 )     4,000  
                 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
    30,404       4,000  

 

 
 

 


 
BIOCUBE, INC.
(A Development Stage Company)
INCOME STATEMENTS
DECEMBER 31, 2009 AND 2008

   
Year ended
Dec 31, 2009
   
Year ended
Dec 31, 2008
 
REVENUE
           
             
Total Revenue
  $ 0     $ 0  
                 
OPERATING EXPENSES
               
General and administrative expense
    230,640       4,000  
                 
Total Operating Expenses
    230,640       4,000  
                 
Operating Income (Loss)
    (230,640 )     (4,000 )
                 
Income (Loss) Before Income Taxes
    (230,640 )     (4,000 )
                 
Provision for Income Tax
    0       0  
                 
Net Income (Loss)
  $ (230,640 )   $ (4,000 )








 

 



BIOCUBE, INC.
(A Development Stage Company)
STATEMENTS OF CASH FLOW
DECEMBER 31, 2009 AND 2008

   
Year ended
Dec 31, 2009
   
Year ended
Dec 31, 2008
 
CASH FLOWS FROM OPERATING ACTIVITIES
           
             
NET INCOME
           
Net Income (Loss)
  $ (230,640 )   $ (4,000 )
                 
Total Net Income
    (230,640 )     (4,000 )
                 
ADJUSTMENTS TO NET INCOME
               
                 
Adjustments to reconcile Net Income (Loss) to net Cash:
               
Increase (Decrease) in:
               
Accounts Payable
    26,600       0  
Accrued salaries
    180,000       0  
Other accrued expenses
    269       0  
Short term loans
    14,175       0  
                 
Total Adjustments
    221,044       0  
                 
Net Cash Provided By (Used In) Operating Activities
    (9,596 )     (4,000 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES
               
Decontamination system
    (28,500 )     0  
                 
Net Cash Provided By (Used In) Investing Activities
    (28,500 )     0  
                 
CASH FLOWS FROM FINANCING ACTIVITIES
               
Note payable Leaddog
    10,000       0  
Capital Stock
    30,000       4,000  
                 
Net Cash Provided By (Used In) Financing Activities
    40,000       4,000  
                 
NET INCREASE (DECREASE) IN CASH
  $ 1,904     $ 0  
                 
CASH AT BEGINNING OF PERIOD
    0       0  
                 
CASH AT END OF PERIOD
  $ 1,904     $ 0  
                 


3